Standard versus simplified radiofrequency ablation protocol for Barrett’s esophagus: comparative analysis of the whole treatment pathway

Abstract

Background and study aims The standard radiofrequency ablation (RFA) protocol for Barrett’s esophagus (BE) encompasses an intermediary cleaning phase between two ablation sessions. A simplified protocol omitting the cleaning phase is less labor-intensive but equally effective in studies based on single ablation procedures. The aim of this study was to compare efficacy and safety of the standard and simplified RFA protocols for the whole treatment pathway for BE, including both circumferential and focal devices.

Patients and methods We performed a retrospective analysis of prospectively collected data on patients receiving RFA between January 2007 and August 2017 at two institutions. Outcomes assessed were: 1) complete remission of dysplasia (CR-D) and intestinal metaplasia (CR-IM) at 18 months; and 2) rate of esophageal strictures.

Results One hundred forty-five patients were included of whom 73 patients received the standard and 72 patients received the simplified protocol. CR-D was achieved in 94.5 % and 95.8 % of patients receiving the standard and simplified protocol, respectively (P = 0.71). CR-IM was achieved in 84.9 % and 77.8 % of patients treated with the standard and simplified protocol, respectively (P = 0.27). Strictures were significantly more common among patients who received the simplified protocol (12.5 %) compared to the standard protocol (1.4 %; P = 0.008). The median number of esophageal dilations was one.

Conclusion The simplified RFA protocol is as effective as the standard protocol in eradicating BE but carries a higher risk of strictures. This needs to be taken into account, particularly in patients with higher pretreatment risk of strictures, such as those with esophageal narrowing from previous endoscopic mucosal resection (EMR).

• References

• 1 Spechler SJ, Souza RF. Barret’s esophagus. N Engl J Med 2014; 371: 836-845
• 2 Tan WK, di Pietro M, Fitzgerald RC. Past, present and future of Barrett’s oesophagus. Europ J Surg Oncol 2017; 43: 1148-1160
• 3 Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med 2014; 371: 2499-2509
• 4 Shaheen NJ, Sharma P, Overholt BF. et al. Radiofrequency ablation in Barrettʼs esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
• 5 Phoa KN, Pouw RE, Van Vilsteren FG. et al. Remission of Barrettʼs esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 2013; 145: 96-104
• 6 Shaheen NJ, Overholt BF, Sampliner RE. et al. Durability of radiofrequency ablation in Barrettʼs esophagus with dysplasia. Gastroenterology 2011; 141: 460-468
• 7 Tan WK, Rattan A, O’Donovan M. et al. Comparative outcomes of radiofrequency ablation for Barrett’s oesophagus with different baseline histology. United European Gastroenterology 2018; 6: 662-668
• 8 Pouw RE, Wirths K, Eisendrath P. et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrettʼs esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010; 8: 23-29
• 9 Pouw RE, Gondrie JJ, Rygiel AM. et al. Properties of the neosquamous epithelium after radiofrequency ablation of Barrettʼs esophagus containing neoplasia. The American journal of gastroenterology 2009; 104: 1366-1373
• 10 Gondrie J, Pouw R, Sondermeijer C. et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008; 40: 370-379
• 11 Gondrie J, Pouw R, Sondermeijer C. et al. Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008; 40: 359-369
• 12 van Vilsteren FG, Phoa KN, Herrero LA. et al. Circumferential balloon-based radiofrequency ablation of Barrettʼs esophagus with dysplasia can be simplified, yet efficacy maintained, by omitting the cleaning phase. Clin Gastroenterol Hepatol 2013; 11: 491-498. e491
• 13 van Vilsteren FG, Phoa KN, Alvarez Herrero L. et al. A simplified regimen for focal radiofrequency ablation of Barrettʼs mucosa: a randomized multicenter trial comparing two ablation regimens. Gastrointest Endosc 2013; 78: 30-38
• 14 Kunzli HT, Scholvinck DW, Phoa KN. et al. Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrettʼs esophagus. Endoscopy 2015; 47: 592-597
• 15 Schlemper RJ, Riddell RH, Kato Y. et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255
• 16 Sharma P, Dent J, Armstrong D. et al. The development and validation of an endoscopic grading system for Barrettʼs esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-1399
• 17 Spechler SJ, Sharma P, Souza RF. et al. American Gastroenterological Association technical review on the management of Barrettʼs esophagus. Gastroenterology 2011; 140: e18
• 18 Axon A, Diebold M, Fujino M. et al. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005; 37: 570-578
• 19 Fitzgerald RC, di Pietro M, Ragunath K. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrettʼs oesophagus. Gut 2014; 63: 7-42
• 20 di Pietro M, Fitzgerald RC. Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrettʼs oesophagus with low-grade dysplasia. Gut 2018; 67: 392-393
• 21 Pouw RE, Künzli HT, Bisschops R. et al. Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrettʼs oesophagus: a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 2018; 3: 566-574
• 22 Pouw RE, Bergman JJ. Safety signal for the simple double ablation regimen when using the Barrx 360 Express radiofrequency ablation balloon catheter. Gastroenterology 2017; 153: 614
• 23 Magee C, Gordon C, Dunn J. et al. OTU-013 Outcomes of 360 HALO express radio-frequency ablation for barrett’s oesophagus related neoplasia. Gut. 2018 67: (Suppl. 01)
• 24 Haidry RJ, Dunn JM, Butt MA. et al. Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrettʼs esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology 2013; 145: 87-95